Diabetes Screening in the Emergency Department: Development of a Predictive Model for Elevated Hemoglobin A1c
- PMID: 40109952
- PMCID: PMC11922610
- DOI: 10.1155/jdr/8830658
Diabetes Screening in the Emergency Department: Development of a Predictive Model for Elevated Hemoglobin A1c
Abstract
Aims: We developed a prediction model for elevated hemoglobin A1c (HbA1c) among patients presenting to the emergency department (ED) at risk for diabetes to identify important factors that may influence follow-up patient care. Methods: Retrospective electronic health records data among patients screened for diabetes at the ED in May 2021 was used. The primary outcome was elevated HbA1c (≥ 5.7%). The data was divided into a derivation set (80%) and a test set (20%) stratified by elevated HbA1c. In the derivation set, we estimated the optimal significance level for backward elimination using a 10-fold cross-validation method. A final model was derived using the entire derivation set and validated on the test set. Performance statistics included C-statistic, sensitivity, specificity, predictive values, Hosmer-Lemeshow test, and Brier score. Results: There were 590 ED patients screened for diabetes in May 2021. The final model included nine variables: age, race/ethnicity, insurance, chief complaints of back pain and fever/chills, and a past medical history of obesity, hyperlipidemia, chronic obstructive pulmonary disease, and substance misuse. Adequate model discrimination (C-statistic = 0.75; sensitivity, specificity, and predictive values > 0.70), no evidence of model ill fit (Hosmer-Lemeshow test = 0.29), and moderate Brier score (0.21) suggest acceptable model performance. Conclusion: In addition to age, obesity, and hyperlipidemia, a history of substance misuse was identified as an important predictor of elevated HbA1c levels among patients screened for diabetes in the ED. Our findings suggest that substance misuse may be an important factor to consider when facilitating follow-up care for patients identified with prediabetes or diabetes in the ED and warrants further investigation. Future research efforts should also include external validation in larger samples of ED patients.
Copyright © 2025 Mary H. Smart et al. Journal of Diabetes Research published by John Wiley & Sons Ltd.
Conflict of interest statement
J.Y.L. reported receiving grant funding from Novo Nordisk A/S during the conduct of the study and Xeris Biopharma Holdings Inc. outside of the submitted work. B.T.L. is supported by the National Institutes of Health under Award Number R01DK104927 and P30DK020595 and the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, VA merit (Grant No. 1I01BX003382). K.K.D. reported receiving grant funding from Novo Nordisk A/S during the conduct of this study. The other authors declare no conflicts of interest.
References
-
- Centers for Disease Control and Prevention. National Diabetes Statistics Report website. Updated June 29, 2022. Accessed October 7, 2023. https://www.cdc.gov/diabetes/data/statistics-report/index.html.
-
- Arnett M. J., Thorpe R. J., Jr., Gaskin D. J., Bowie J. V., LaVeist T. A. Race, medical mistrust, and segregation in primary care as usual source of care: findings from the exploring health disparities in integrated communities study. Journal of Urban Health . 2016;93(3):456–467. doi: 10.1007/s11524-016-0054-9. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
